New recommendations aim to eliminate racial bias in myeloma trials
(Dana-Farber Cancer Institute) Recommendations designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: African Health | Cancer | Cancer & Oncology | Clinical Trials | International Medicine & Public Health | Myeloma